These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15758738)

  • 1. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
    Mayer R; Propert KJ; Peters KM; Payne CK; Zhang Y; Burks D; Culkin DJ; Diokno A; Hanno P; Landis JR; Madigan R; Messing EM; Nickel JC; Sant GR; Warren J; Wein AJ; Kusek JW; Nyberg LM; Foster HE;
    J Urol; 2005 Apr; 173(4):1186-91. PubMed ID: 15758738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
    Propert KJ; Mayer R; Nickel JC; Payne CK; Peters KM; Teal V; Burks D; Kusek JW; Nyberg LM; Foster HE;
    J Urol; 2007 Sep; 178(3 Pt 1):886-90. PubMed ID: 17631335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup.
    Peters KM; Diokno AC; Steinert BW; Gonzalez JA
    J Urol; 1998 May; 159(5):1483-6; discussion 1486-7. PubMed ID: 9554338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.
    Peters K; Diokno A; Steinert B; Yuhico M; Mitchell B; Krohta S; Gillette B; Gonzalez J
    J Urol; 1997 Jun; 157(6):2090-4. PubMed ID: 9146587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
    Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM;
    J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis.
    Aghamir SM; Mohseni MG; Arasteh S
    Urol J; 2007; 4(1):18-23. PubMed ID: 17514606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
    Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
    Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
    Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
    J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.
    van Ophoven A; Pokupic S; Heinecke A; Hertle L
    J Urol; 2004 Aug; 172(2):533-6. PubMed ID: 15247722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M; Saint F; Chopin D; Malavaud B; Nicolas L; Rischmann P
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
    Peng CH; Kuo HC
    Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of intravesical Bacillus-Calmette-Guerin in the treatment of female patients with interstitial cystitis: a double-blinded prospective placebo controlled study.
    Irani D; Heidari M; Khezri AA
    Urol J; 2004; 1(2):90-3. PubMed ID: 17874392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.
    Sant GR; Propert KJ; Hanno PM; Burks D; Culkin D; Diokno AC; Hardy C; Landis JR; Mayer R; Madigan R; Messing EM; Peters K; Theoharides TC; Warren J; Wein AJ; Steers W; Kusek JW; Nyberg LM;
    J Urol; 2003 Sep; 170(3):810-5. PubMed ID: 12913705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo.
    Propert KJ; Mayer R; Nickel JC; Payne CK; Peters KM; Teal V; Burks D; Kusek JW; Nyberg LM; Foster HE;
    J Urol; 2008 Feb; 179(2):552-5. PubMed ID: 18082224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C.
    Ojea A; Nogueira JL; Solsona E; Flores N; Gómez JM; Molina JR; Chantada V; Camacho JE; Piñeiro LM; Rodríguez RH; Isorna S; Blas M; Martínez-Piñeiro JA; Madero R;
    Eur Urol; 2007 Nov; 52(5):1398-406. PubMed ID: 17485161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.